Literature DB >> 15770739

Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas.

De-Bin Liu1, Zhen-Dong Gu, Xiao-Zhe Cao, Hong Liu, Ji-You Li.   

Abstract

AIM: To evaluate the expression pattern of two novel oncofetal antigens, the HoxD9 and Pbx1 homeoproteins in esophageal squamous cell carcinomas (ESCCs) to determine what role they would play in the carcinogenesis of ESCC.
METHODS: We obtained tissue samples of ESCC from 56 patients who underwent esophagectomy but not preoperative chemotherapy or radiotherapy. The diagnosis of ESCC was established and confirmed by staff pathologists. We used a highly sensitive, indirect, immunocytochemical method to detect HoxD9 and PbX1 proteins. We qualitatively and quantitatively evaluated cells that exhibited and staining using a light microscope.
RESULTS: In all observed carcinoma tissue samples, more than 60% of neoplastic cells stained lightly or strongly for HoxD9, and more than 50% of neoplastic cells stained lightly or strongly for Pbx1.
CONCLUSION: Our data suggest that HoxD9 and Pbx1 are inappropriately expressed in most human esophageal squamous cell carcinoma. Understanding the role of Hox genes in esophageal epithelial cell carcinogenesis may not only augment early detection but also offer new avenues for treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770739      PMCID: PMC4305705          DOI: 10.3748/wjg.v11.i10.1562

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Cell-type-specific modulation of Hox gene expression by members of the TGF-beta superfamily: a comparison between human osteosarcoma and neuroblastoma cell lines.

Authors:  P Kloen; M H Visker; W Olijve; E J van Zoelen; C J Boersma
Journal:  Biochem Biophys Res Commun       Date:  1997-04-17       Impact factor: 3.575

2.  PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1.

Authors:  K Monica; N Galili; J Nourse; D Saltman; M L Cleary
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

Review 3.  Effects of HOX homeobox genes in blood cell differentiation.

Authors:  M C Magli; C Largman; H J Lawrence
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

4.  Homeobox B3, B4, and C6 gene product expression in osteosarcomas as detected by immunocytochemistry.

Authors:  B Bodey; B Bodey; S E Siegel; J V Luck; H E Kaiser
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

5.  Immunocytochemical detection of homeobox B3, B4, and C6 gene product expression in lung carcinomas.

Authors:  B Bodey; B Bodey; A M Gröger; S E Siegel; H E Kaiser
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

6.  Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

7.  Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.

Authors:  K Monica; D P LeBrun; D A Dedera; R Brown; M L Cleary
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  HOX gene expression in normal and neoplastic human kidney.

Authors:  C Cillo; P Barba; G Freschi; G Bucciarelli; M C Magli; E Boncinelli
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

9.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

10.  HOX4 genes encode transcription factors with potential auto- and cross-regulatory capacities.

Authors:  V Zappavigna; A Renucci; J C Izpisúa-Belmonte; G Urier; C Peschle; D Duboule
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  6 in total

1.  TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.

Authors:  Chaya Levovitz; Dan Chen; Emma Ivansson; Ulf Gyllensten; John P Finnigan; Sara Alshawish; Weijia Zhang; Eric E Schadt; Marshal R Posner; Eric M Genden; Paolo Boffetta; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

2.  Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells.

Authors:  Masanao Tabuse; Shigeki Ohta; Yohei Ohashi; Raita Fukaya; Aya Misawa; Kazunari Yoshida; Takeshi Kawase; Hideyuki Saya; Cécile Thirant; Hérve Chneiweiss; Yumi Matsuzaki; Hideyuki Okano; Yutaka Kawakami; Masahiro Toda
Journal:  Mol Cancer       Date:  2011-05-22       Impact factor: 27.401

3.  PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.

Authors:  Luca Magnani; Elizabeth B Ballantyne; Xiaoyang Zhang; Mathieu Lupien
Journal:  PLoS Genet       Date:  2011-11-17       Impact factor: 5.917

Review 4.  None-endoscopic Screening for Esophageal Squamous Cell Carcinoma- A Review.

Authors:  Gholamreza Roshandel; Shahryar Semnani; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2012-04

5.  HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.

Authors:  Mengwei Liu; Yizhi Xiao; Weimei Tang; Jiaying Li; Linjie Hong; Weiyu Dai; Wenjing Zhang; Ying Peng; Xiaosheng Wu; Jing Wang; Yaying Chen; Yang Bai; Jianjiao Lin; Qiong Yang; Yusi Wang; Zhizhao Lin; Side Liu; Jing Xiong; Jide Wang; Li Xiang
Journal:  Cancer Med       Date:  2020-04-12       Impact factor: 4.452

6.  HOXD9 Activates the TGF-β/Smad Signaling Pathway to Promote Gastric Cancer.

Authors:  Rui Xiong; Tao Yin; Jian-Long Gao; Yu-Feng Yuan
Journal:  Onco Targets Ther       Date:  2020-03-10       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.